SCHEMBL230582

SCHEMBL230582

O=S(=O)(O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.55
LMNA P02545 1/20 0.52
TSHR P16473 2/20 0.50
ALDH1A1 P00352 2/20 0.50
NT5E P21589 1/20 0.50
CA1 P00915 4/20 0.49
CA2 P00918 4/20 0.49
CA9 Q16790 2/20 0.49
CA12 O43570 1/20 0.49
MAPT P10636 1/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MMP1 P03956 2/20 0.47
AKR1B1 P15121 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
PTGS2 P35354 2/20 0.44
PTGS1 P23219 1/20 0.44
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6115108 0.98 KIF11 (0.53) KIF11LMNATSHRALDH1A1NT5E
SCHEMBL15568689 0.98 KIF11 (0.53) KIF11LMNATSHRALDH1A1NT5E
Hydrochloric Acid SCHEMBL4589695 0.98 KIF11 (0.53) KIF11LMNATSHRALDH1A1NT5E
Ethylene SCHEMBL28421049 0.96 KIF11 (0.52) KIF11LMNATSHRALDH1A1NT5E
SCHEMBL2894832 0.94 KIF11 (0.66) KIF11LMNAMMP1PTGS2PTGS1
SCHEMBL16563273 0.92 KIF11 (0.48) KIF11LMNATSHRALDH1A1NT5E
SCHEMBL2882142 0.92 LMNA (0.50) KIF11LMNATSHRALDH1A1NT5E
SCHEMBL16563207 0.92 KIF11 (0.48) KIF11LMNATSHRALDH1A1NT5E
SCHEMBL16563205 0.90 KIF11 (0.47) KIF11LMNATSHRALDH1A1NT5E
SCHEMBL30868599 0.88 CA1 (0.50) KIF11LMNATSHRALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12467015-B2 Method of making fatty acid esters REC RELIABLE ENGINEERING CONCEPTS GMBH (DE) 2025-11-11 US claimed
EP-4607278-A1 CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT Ycchem Co., Ltd. (KR) 2025-08-27 EP claimed
US-20250199405-A1 CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT YCCHEM CO., LTD. (KR) 2025-06-19 US claimed
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) 2025-06-12 US claimed
CN-119998727-A Chemically amplified positive resist composition for improving pattern profile and enhancing etch resistance YC化学制品株式会社 2025-05-13 CN claimed
CN-119771400-A Metal nanocluster, preparation method and application thereof, and method for coupling terminal olefin with benzyl alcohol compound 中国石油化工股份有限公司 2025-04-08 CN claimed
CN-119775230-A Preparation method and application of tetrahydrofuran cyclostyrenes compound 中国石油化工股份有限公司 2025-04-08 CN claimed
CN-119775113-A UV absorbing compounds and photoresist compositions containing the same 湖北鼎龙芯盛科技有限公司 2025-04-08 CN claimed
CN-119708052-A Compound for polyolefin antioxidation and preparation and application thereof 中国石油天然气股份有限公司 2025-03-28 CN claimed
EP-4477651-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND Jiangsu Celluranics New Material Technology Co., Ltd. (CN) 2024-12-18 EP claimed
US-20020015906-A1 Polymer for photoresist, method of production thereof and photoresist composition containing polymer SAMSUNG ELECTRONICS CO., LTD. (KR) 2002-02-07 US claimed
EP-0807652-B1 Process for producing fibre-reinforced compositions CIBA SC HOLDING AG (CH) 2001-11-14 EP claimed
US-6100323-A A POLYALKENAMER FROM A RING-OPENING METATHESIS POLYMERISATION, AS PROTECTIVE COATING MATERIAL FOR ELECTRICAL AND ELECTRONIC COMPONENTS; HAVING A HIGH GLASS TRANSITION TEMPERATURE CIBA SPECIALTY CHEMICALS CORP. (US) 2000-08-08 US claimed
EP-0794207-B1 Curable composition containing a cyclopentadiene Diels-Alder adduct and a filler CIBA SC HOLDING AG (CH) 2000-05-03 EP claimed
US-6001909-A RING OPENING METATHESIS POLYMERIZATION WITH COORDINATION CATALYSTS FOR CYCLOOLEFINS CIBA SPECIALTY CHEMICALS CORP. (US) 1999-12-14 US claimed
US-5840238-A Process for the manufacture of fibre-reinforced composites CIBA SPECIALTY CHEMICALS CORPORATION (US) 1998-11-24 US claimed
EP-0807652-A2 Process for producing fibre-reinforced compositions Ciba SC Holding AG (CH) 1997-11-19 EP claimed
EP-0794207-A2 Curable composition containing a cyclopentadiene Diels-Alder adduct and a filler Ciba SC Holding AG (CH) 1997-09-10 EP claimed
EP-0771830-A2 Curable composition containing cycloolefins, silane and filler Ciba SC Holding AG (CH) 1997-05-07 EP claimed
EP-0569884-B1 Rust inhibitor UNION CHEMICAL CO LTD (JP) 1996-09-18 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND HPD, DPYD, PGD KIF11 1854/4885LMNA 3104/4885TSHR 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.